NYBCe and CZ Biohub will derive iPSC lines from cord blood's immune cells, creating shared, broadly compatible resources for cell therapy, disease modelling, and AI-driven drug development.
The human blood system is in a constant state of turnover. First-line immune defenders, like neutrophils, need to be replaced after just four to eight hours, platelets can last a week, red blood cells ...
Hosted on MSN
From stem cell to lifeline: the journey of blood
Your blood is constantly renewed by a hidden army—hematopoietic stem cells in your bone marrow. These cells can create every type of blood cell, but new research shows some are surprisingly picky, ...
Tracking how blood cancers develop over time has uncovered important genetic differences between patients whose disease stays ...
Add Yahoo as a preferred source to see more of our stories on Google. Currently, to treat conditions such as leukaemia, damaged blood cells need to be replaced in a stem cell transplant. But ...
Some blood cancers move with eerie patience. A patient can feel well for years, their blood counts looking steady, their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results